FindTrial
Sign In

Suspension from Patients own skin for correction of depressed area of face

Autologous non cultured dermal cell suspension for correction of facial volume loss

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/11/007500
Enrollment
10
Registered
2016-11-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patient having visible volume defect over face

Interventions

Intervention1: Injection of autologous dermal cell suspension: Patient own dermis is collected by excision biopsy, subjected to collagenase to produce cell suspension that is injected to dermis for co

Sponsors

AIIMS New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient with visible volume loss on face. 2.Controlled underlying systemic disease for at least last 6 months

Exclusion criteria

Exclusion criteria: 1.Pregnancy and lactation 2.Keloid or bleeding diathesis 3.Active infection at the treatment site. 4 .Patient having profound iatrogenic immunosuppression. 5.Patient with unrealistic expectations and body dysmorphic disorder. 6. Inability to come for follow up upto 6 month.

Design outcomes

Primary

MeasureTime frame
Clinical subjective and photographic improvement in the volume loss Timepoint: 6 months—

Secondary

MeasureTime frame
Objective improvement in the volume loss measured by Ultrasonography of the skinTimepoint: 6 months—

Countries

India

Contacts

Public ContactDr Alok kumar Sahoo

AIIMS ,NewDelhi

iusti2011@gmail.com01126596626

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026